Ipoglicemia nel paziente diabetico anziano fragile

Translated title of the contribution: Hypoglycemia in the frail elderly diabetic patient

A. Rauseo, A. Pacilli, R. Viti, A. Palena, S. Bacci, G. D’amico, M. A. Annese, P. Piscitelli, A. Greco, Salvatore De Cosmo

Research output: Contribution to journalArticle

Abstract

Diabetes is very common among the elderly. In Italy, more than 20% of people older than 75 suffer from the disease. Many of them are frail, with extensive comorbid conditions, or long-standing diabetes in whom the risk of hypoglycemia is very high. An appropriate multidimensional approach is therefore needed when assessing geriatric syndromes, including frailty, cognitive impairment, poor mobility, reduced vision and hearing, depression, and chronic pain. Although in the last few years the benefits of intensive glucose treatment have been described, it is becoming increasingly clear that over-treatment, particularly in older adults, is a significant problem given the fact that hypoglycemia is related to a number of adverse conditions, including mortality. Consequently, and in the light of a “patient-centered approach”, less stringent A1c goals (such as <8.0-8.5%) may be appropriate for these patients. The risk of hypoglycemia is highest with insulin and sulphonyl - ureas, mainly glibenclamide. These latter drugs should be avoid in older diabetics. New hypoglycemic agents with a very low risk of hypoglycemia have recently been introduced on the market. This review assesses these drugs and insulin analogs.

Original languageItalian
Pages (from-to)239-246
Number of pages8
JournalGiornale Italiano di Diabetologia e Metabolismo
Volume35
Issue number3
Publication statusPublished - Sep 1 2015

Fingerprint

Frail Elderly
Hypoglycemia
Insulin
Low Vision
Glyburide
Hypoglycemic Agents
Chronic Pain
Geriatrics
Pharmaceutical Preparations
Italy
Hearing
Urea
Depression
Glucose
Mortality
Therapeutics

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Ipoglicemia nel paziente diabetico anziano fragile. / Rauseo, A.; Pacilli, A.; Viti, R.; Palena, A.; Bacci, S.; D’amico, G.; Annese, M. A.; Piscitelli, P.; Greco, A.; De Cosmo, Salvatore.

In: Giornale Italiano di Diabetologia e Metabolismo, Vol. 35, No. 3, 01.09.2015, p. 239-246.

Research output: Contribution to journalArticle

Rauseo, A, Pacilli, A, Viti, R, Palena, A, Bacci, S, D’amico, G, Annese, MA, Piscitelli, P, Greco, A & De Cosmo, S 2015, 'Ipoglicemia nel paziente diabetico anziano fragile', Giornale Italiano di Diabetologia e Metabolismo, vol. 35, no. 3, pp. 239-246.
Rauseo, A. ; Pacilli, A. ; Viti, R. ; Palena, A. ; Bacci, S. ; D’amico, G. ; Annese, M. A. ; Piscitelli, P. ; Greco, A. ; De Cosmo, Salvatore. / Ipoglicemia nel paziente diabetico anziano fragile. In: Giornale Italiano di Diabetologia e Metabolismo. 2015 ; Vol. 35, No. 3. pp. 239-246.
@article{1975602ce9e3408eadf781f8da927db9,
title = "Ipoglicemia nel paziente diabetico anziano fragile",
abstract = "Diabetes is very common among the elderly. In Italy, more than 20{\%} of people older than 75 suffer from the disease. Many of them are frail, with extensive comorbid conditions, or long-standing diabetes in whom the risk of hypoglycemia is very high. An appropriate multidimensional approach is therefore needed when assessing geriatric syndromes, including frailty, cognitive impairment, poor mobility, reduced vision and hearing, depression, and chronic pain. Although in the last few years the benefits of intensive glucose treatment have been described, it is becoming increasingly clear that over-treatment, particularly in older adults, is a significant problem given the fact that hypoglycemia is related to a number of adverse conditions, including mortality. Consequently, and in the light of a “patient-centered approach”, less stringent A1c goals (such as <8.0-8.5{\%}) may be appropriate for these patients. The risk of hypoglycemia is highest with insulin and sulphonyl - ureas, mainly glibenclamide. These latter drugs should be avoid in older diabetics. New hypoglycemic agents with a very low risk of hypoglycemia have recently been introduced on the market. This review assesses these drugs and insulin analogs.",
keywords = "Diabetes mellitus, Elderly, Glicemic control, Glycated hemoglobin, Intensive hypoglycemic therapy",
author = "A. Rauseo and A. Pacilli and R. Viti and A. Palena and S. Bacci and G. D’amico and Annese, {M. A.} and P. Piscitelli and A. Greco and {De Cosmo}, Salvatore",
year = "2015",
month = "9",
day = "1",
language = "Italian",
volume = "35",
pages = "239--246",
journal = "Giornale Italiano di Diabetologia",
issn = "1593-6104",
publisher = "UTET Periodici Scientifici srl",
number = "3",

}

TY - JOUR

T1 - Ipoglicemia nel paziente diabetico anziano fragile

AU - Rauseo, A.

AU - Pacilli, A.

AU - Viti, R.

AU - Palena, A.

AU - Bacci, S.

AU - D’amico, G.

AU - Annese, M. A.

AU - Piscitelli, P.

AU - Greco, A.

AU - De Cosmo, Salvatore

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Diabetes is very common among the elderly. In Italy, more than 20% of people older than 75 suffer from the disease. Many of them are frail, with extensive comorbid conditions, or long-standing diabetes in whom the risk of hypoglycemia is very high. An appropriate multidimensional approach is therefore needed when assessing geriatric syndromes, including frailty, cognitive impairment, poor mobility, reduced vision and hearing, depression, and chronic pain. Although in the last few years the benefits of intensive glucose treatment have been described, it is becoming increasingly clear that over-treatment, particularly in older adults, is a significant problem given the fact that hypoglycemia is related to a number of adverse conditions, including mortality. Consequently, and in the light of a “patient-centered approach”, less stringent A1c goals (such as <8.0-8.5%) may be appropriate for these patients. The risk of hypoglycemia is highest with insulin and sulphonyl - ureas, mainly glibenclamide. These latter drugs should be avoid in older diabetics. New hypoglycemic agents with a very low risk of hypoglycemia have recently been introduced on the market. This review assesses these drugs and insulin analogs.

AB - Diabetes is very common among the elderly. In Italy, more than 20% of people older than 75 suffer from the disease. Many of them are frail, with extensive comorbid conditions, or long-standing diabetes in whom the risk of hypoglycemia is very high. An appropriate multidimensional approach is therefore needed when assessing geriatric syndromes, including frailty, cognitive impairment, poor mobility, reduced vision and hearing, depression, and chronic pain. Although in the last few years the benefits of intensive glucose treatment have been described, it is becoming increasingly clear that over-treatment, particularly in older adults, is a significant problem given the fact that hypoglycemia is related to a number of adverse conditions, including mortality. Consequently, and in the light of a “patient-centered approach”, less stringent A1c goals (such as <8.0-8.5%) may be appropriate for these patients. The risk of hypoglycemia is highest with insulin and sulphonyl - ureas, mainly glibenclamide. These latter drugs should be avoid in older diabetics. New hypoglycemic agents with a very low risk of hypoglycemia have recently been introduced on the market. This review assesses these drugs and insulin analogs.

KW - Diabetes mellitus

KW - Elderly

KW - Glicemic control

KW - Glycated hemoglobin

KW - Intensive hypoglycemic therapy

UR - http://www.scopus.com/inward/record.url?scp=84942759913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942759913&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:84942759913

VL - 35

SP - 239

EP - 246

JO - Giornale Italiano di Diabetologia

JF - Giornale Italiano di Diabetologia

SN - 1593-6104

IS - 3

ER -